United Therapeutics Corporation (UTHR) /
The revenue of United Therapeutics Corporation over the past 10 years
Chart United Therapeutics Corporation: revenue, fiscal 2016–2025 Open the chart →United Therapeutics Corporation reported revenue of $3.18B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $1.6B — up 99% over 9 years. Year over year, revenue rose 7 times and fell twice. In these years the lowest $1.45B in fiscal 2019. The largest one-year move was in fiscal 2024: up 24%, from $2.33B to $2.88B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $3.18B |
| 2024ended Dec 31, 2024 | $2.88B |
| 2023ended Dec 31, 2023 | $2.33B |
| 2022ended Dec 31, 2022 | $1.94B |
| 2021ended Dec 31, 2021 | $1.69B |
| 2020ended Dec 31, 2020 | $1.48B |
| 2019ended Dec 31, 2019 | $1.45B |
| 2018ended Dec 31, 2018 | $1.63B |
| 2017ended Dec 31, 2017 | $1.73B |
| 2016ended Dec 31, 2016 | $1.6B |
Fiscal years as United Therapeutics Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on United Therapeutics Corporation
- The profitability of United Therapeutics Corporation
- The cash flow of United Therapeutics Corporation
- The debt of United Therapeutics Corporation
- All of United Therapeutics Corporation's financials, charted
Companies of a similar size
- LHLABCORP HOLDINGS INC.
- ULTAULTA BEAUTY, INC.
- DGXQuest Diagnostics Inc
- DOVDOVER Corp
- CNPCENTERPOINT ENERGY INC
Not investment advice. This page shows what United Therapeutics Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.